Showing results (1301-1310 of 1,842) with videos related to

Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|December 13, 2023
Medicare drug price negotiation: The complexities of selecting therapeutic alternatives for estimating comparative effectivenessInmaculada Hernandez, Emma M Cousin, Olivier J Wouters, et al.
Journal of Managed Care & Specialty Pharmacy|March 14, 2024
Specialty drug use for autoimmune conditions varies by race and wage among employees with employer-sponsored health insuranceBruce W Sherman, Rochelle Henderson, Leah Kamin, et al.
Journal of Managed Care & Specialty Pharmacy|March 1, 2024
A primer on quality measurement and reporting in pharmacy benefit plansStephen J Kogut
Journal of Managed Care & Specialty Pharmacy|February 3, 2024
Burden of chronic corticosteroid use among patients with ulcerative colitis initiated on targeted treatment or conventional therapy in the United StatesMaryia Zhdanava, Ruizhi Zhao, Ameur M Manceur, et al.
Journal of Managed Care & Specialty Pharmacy|February 3, 2024
Impact of formulary-related pharmacy claim rejections of cariprazine on health care utilization and treatment patterns among patients with bipolar I disorderFrançois Laliberté, Enrico Zanardo, Sean D MacKnight, et al.
Journal of Managed Care & Specialty Pharmacy|January 30, 2024
A summit on amplifying voices of patients, caregivers, and people with disabilities in Inflation Reduction Act drug price negotiationsMaxine Miller, Sara van Geertruyden, M Claire Saxton, et al.
Journal of Managed Care & Specialty Pharmacy|June 2, 2024
Cost-effectiveness of eculizumab and efgartigimod for the treatment of anti-acetylcholine receptor antibody-positive generalized myasthenia gravisPei-Wen Lien, Mrinmayee Joshi, Jeffrey A Tice, et al.
Journal of Managed Care & Specialty Pharmacy|June 2, 2024
Racial and ethnic disparities related to the Medicare Part D Medication Therapy Management ProgramAudrey Allen, Anna Hung
Journal of Managed Care & Specialty Pharmacy|June 7, 2024
Cost burden of cirrhosis and liver disease progression in metabolic dysfunction-associated steatohepatitis: A US cohort studyJ Collin Fishman, Christina Qian, Yestle Kim, et al.
Pageof 185